ShareValue scores for 000766.SHE: Valuation 20, Quality 44, Growth 54, Health 30.

000766.SHE
SZSE

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

CN¥17.08(-0.06%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-10% to 10%
Valuation
20
Overvalued
Price vs Value
Quality
44
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
30
Stressed
Financial Stability
Momentum
11
Bearish
Price Trend

Company Details

About

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China. Address: No. 999, Jinma Road, Tonghua, China, 134003

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026